WO2005084636A3 - A process for the preparation of controlled-release pharmaceutical composition of metoprolol - Google Patents
A process for the preparation of controlled-release pharmaceutical composition of metoprolol Download PDFInfo
- Publication number
- WO2005084636A3 WO2005084636A3 PCT/IB2005/000501 IB2005000501W WO2005084636A3 WO 2005084636 A3 WO2005084636 A3 WO 2005084636A3 IB 2005000501 W IB2005000501 W IB 2005000501W WO 2005084636 A3 WO2005084636 A3 WO 2005084636A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metoprolol
- release pharmaceutical
- pharmaceutical composition
- controlled
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN305DE2004 | 2004-02-27 | ||
IN305/DEL/2004 | 2004-02-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005084636A2 WO2005084636A2 (en) | 2005-09-15 |
WO2005084636A3 true WO2005084636A3 (en) | 2006-11-30 |
Family
ID=34917507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/000501 WO2005084636A2 (en) | 2004-02-27 | 2005-02-25 | A process for the preparation of controlled-release pharmaceutical composition of metoprolol |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005084636A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005060393A1 (en) | 2005-12-16 | 2007-06-21 | Add Advanced Drug Delivery Technologies Ltd. | Pharmaceutical pellet, useful for the production of tablet, comprises a spherical active agent, preferably metroprololsuccinate, comprising core with smooth surface and a coat on the core, where the active agent release is pH-independent |
CN101516356A (en) * | 2006-02-24 | 2009-08-26 | 特瓦制药工业有限公司 | Metoprolol succinate e.r. tablets and methods for their preparation |
JP5242576B2 (en) | 2007-08-27 | 2013-07-24 | 旭化成ケミカルズ株式会社 | Method for producing crystalline cellulose and granule-containing tablet |
WO2013084089A1 (en) * | 2011-12-09 | 2013-06-13 | Wockhardt Limited | Methods for treating cardiovascular disorder |
CN102973515B (en) * | 2012-11-28 | 2016-12-21 | 康普药业股份有限公司 | One treats hypertension, anginal slow releasing preparation |
CN104274387A (en) * | 2013-07-03 | 2015-01-14 | 广东东阳光药业有限公司 | Metoprolol slow-release composition |
IN2013MU03221A (en) * | 2013-10-14 | 2015-07-03 | Zim Lab Ltd | |
CN105193757A (en) * | 2014-06-23 | 2015-12-30 | 中国人民解放军军事医学科学院毒物药物研究所 | Metoprolol sustained-release composition and preparation method thereof |
CN111419813A (en) * | 2020-05-09 | 2020-07-17 | 深圳市道科思医药有限公司 | Metoprolol succinate sustained-release tablet and preparation method thereof |
WO2022074681A1 (en) * | 2020-10-08 | 2022-04-14 | Harman Finochem Limited | Pharmaceutical compositions with enhanced blend uniformity and content uniformity |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871549A (en) * | 1985-07-19 | 1989-10-03 | Fujisawa Pharmaceutical Co., Ltd. | Time-controlled explosion systems and processes for preparing the same |
US5246714A (en) * | 1985-10-11 | 1993-09-21 | Aktiebolaget Hassle | Drug preparation |
WO2003051340A1 (en) * | 2001-12-19 | 2003-06-26 | Astrazeneca Ab | New film coating |
US20030185887A1 (en) * | 2002-03-28 | 2003-10-02 | Chih-Ming Chen | Controlled release oral dosage form of beta-adrenergic blocking agents |
US20050008701A1 (en) * | 2003-07-11 | 2005-01-13 | Mongkol Sriwongjanva | Formulation and process for drug loaded cores |
-
2005
- 2005-02-25 WO PCT/IB2005/000501 patent/WO2005084636A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871549A (en) * | 1985-07-19 | 1989-10-03 | Fujisawa Pharmaceutical Co., Ltd. | Time-controlled explosion systems and processes for preparing the same |
US5246714A (en) * | 1985-10-11 | 1993-09-21 | Aktiebolaget Hassle | Drug preparation |
WO2003051340A1 (en) * | 2001-12-19 | 2003-06-26 | Astrazeneca Ab | New film coating |
US20030185887A1 (en) * | 2002-03-28 | 2003-10-02 | Chih-Ming Chen | Controlled release oral dosage form of beta-adrenergic blocking agents |
US20050008701A1 (en) * | 2003-07-11 | 2005-01-13 | Mongkol Sriwongjanva | Formulation and process for drug loaded cores |
Also Published As
Publication number | Publication date |
---|---|
WO2005084636A2 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005084636A3 (en) | A process for the preparation of controlled-release pharmaceutical composition of metoprolol | |
IL183871A0 (en) | Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same | |
WO2006011159A3 (en) | Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability | |
WO2006000441A3 (en) | Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride | |
WO2007044796A3 (en) | Pyridazinone compounds as calcilytics | |
WO2007097770A8 (en) | Metoprolol succinate e.r. tablets and methods for their preparation | |
WO2007045462A3 (en) | Novel vanilloid receptor ligands and their use for producing medicaments | |
WO2008064202A3 (en) | Modified-release formulations of calcium receptor-active compounds | |
EP2133140A3 (en) | Fast-release microcapsule products | |
WO2005117843A3 (en) | Sustained release preparations | |
IL210756A0 (en) | Carbostyril compound, process for their preparation and pharmaceutical compositions containing them | |
NO20052683D0 (en) | New pyridopyrimidinone compounds, processes for their preparation and pharmaceutical compositions containing them | |
WO2007072495A3 (en) | Coated tablets having prolonged gastric retention | |
ZA200705119B (en) | Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same | |
WO2003057150A3 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | |
WO2006046114A3 (en) | Osmotic dosage forms providing ascending drug release, and processes for their preparation | |
ZA200602631B (en) | Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
WO2005046727A3 (en) | Ibuprofen-containing soft gelatin capsules | |
WO2004098594A3 (en) | Dosage form containing pantoprazole as active ingredient | |
WO2007110753A3 (en) | Extended release dosage forms of metoprolol | |
WO2008034912A3 (en) | Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof | |
WO2003086362A3 (en) | Method of stabilizing bupropion hydrochloride tablets | |
AU2003231920A1 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
WO2004069145A3 (en) | Anticancer compounds, process for their preparation and pharmaceutical compositions containing them | |
HK1096097A1 (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |